GW Henssler & Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.3M | Buy |
38,523
+284
| +0.7% | +$136K | 0.86% | 46 |
|
|
2026
Q1 | $18.8M | Buy |
38,239
+325
| +0.9% | +$176K | 0.89% | 44 |
|
|
2025
Q4 | $22M | Sell |
37,914
-160
| -0.4% | -$90.5K | 1.06% | 33 |
|
|
2025
Q3 | $18.5M | Buy |
38,074
+1,017
| +3% | +$473K | 0.92% | 42 |
|
|
2025
Q2 | $15M | Buy |
37,057
+347
| +0.9% | +$145K | 0.8% | 53 |
|
|
2025
Q1 | $18.3M | Buy |
36,710
+19,285
| +111% | +$10.4M | 1.05% | 40 |
|
|
2024
Q4 | $10.8M | Hold |
17,425
| – | – | 0.62% | 62 |
|
|
2024
Q3 | $10.8M | Sell |
17,425
-4
| -0% | -$2.37K | 0.61% | 62 |
|
|
2024
Q2 | $9.64M | Sell |
17,429
-72
| -0.4% | -$41.2K | 0.58% | 62 |
|
|
2024
Q1 | $10.2M | Sell |
17,501
-131
| -0.7% | -$73.5K | 0.6% | 63 |
|
|
2023
Q4 | $9.36M | Sell |
17,632
-1,239
| -7% | -$600K | 0.62% | 60 |
|
|
2023
Q3 | $9.55M | Sell |
18,871
-482
| -2% | -$257K | 0.65% | 56 |
|
|
2023
Q2 | $10.1M | Sell |
19,353
-472
| -2% | -$255K | 0.66% | 55 |
|
|
2023
Q1 | $11.4M | Sell |
19,825
-180
| -0.9% | -$101K | 0.76% | 53 |
|
|
2022
Q4 | $11M | Sell |
20,005
-229
| -1% | -$121K | 0.77% | 51 |
|
|
2022
Q3 | $10.3M | Sell |
20,234
-25
| -0.1% | -$14K | 0.77% | 52 |
|
|
2022
Q2 | $11M | Sell |
20,259
-73
| -0.4% | -$40.2K | 0.82% | 52 |
|
|
2022
Q1 | $12M | Sell |
20,332
-94
| -0.5% | -$54K | 0.73% | 54 |
|
|
2021
Q4 | $13.6M | Sell |
20,426
-394
| -2% | -$246K | 0.87% | 49 |
|
|
2021
Q3 | $11.9M | Sell |
20,820
-398
| -2% | -$218K | 0.83% | 56 |
|
|
2021
Q2 | $10.7M | Sell |
21,218
-197
| -0.9% | -$93K | 0.7% | 62 |
|
|
2021
Q1 | $9.77M | Sell |
21,415
-229
| -1% | -$109K | 0.7% | 62 |
|
|
2020
Q4 | $10.1M | Sell |
21,644
-173
| -0.8% | -$81.1K | 0.77% | 56 |
|
|
2020
Q3 | $9.63M | Sell |
21,817
-38
| -0.2% | -$15.7K | 0.82% | 55 |
|
|
2020
Q2 | $7.92M | Sell |
21,855
-940
| -4% | -$315K | 0.7% | 57 |
|
|
2020
Q1 | $6.46M | Sell |
22,795
-1,627
| -7% | -$513K | 0.66% | 57 |
|
|
2019
Q4 | $7.93M | Sell |
24,422
-586
| -2% | -$178K | 0.66% | 60 |
|
|
2019
Q3 | $7.28M | Sell |
25,008
-463
| -2% | -$133K | 0.65% | 59 |
|
|
2019
Q2 | $7.48M | Sell |
25,471
-542
| -2% | -$149K | 0.68% | 58 |
|
|
2019
Q1 | $7.12M | Sell |
26,013
-5,683
| -18% | -$1.41M | 0.65% | 59 |
|
|
2018
Q4 | $7.09M | Sell |
31,696
-1,681
| -5% | -$394K | 0.76% | 57 |
|
|
2018
Q3 | $8.15M | Sell |
33,377
-1,666
| -5% | -$383K | 0.74% | 55 |
|
|
2018
Q2 | $7.26M | Sell |
35,043
-1,930
| -5% | -$410K | 0.71% | 55 |
|
|
2018
Q1 | $7.63M | Sell |
36,973
-3,365
| -8% | -$706K | 0.77% | 56 |
|
|
2017
Q4 | $7.66M | Sell |
40,338
-1,287
| -3% | -$247K | 0.72% | 58 |
|
|
2017
Q3 | $7.88M | Sell |
41,625
-4,143
| -9% | -$750K | 0.79% | 54 |
|
|
2017
Q2 | $7.99M | Sell |
45,768
-1,920
| -4% | -$323K | 0.83% | 53 |
|
|
2017
Q1 | $7.33M | Sell |
47,688
-4,431
| -9% | -$677K | 0.79% | 54 |
|
|
2016
Q4 | $7.35M | Sell |
52,119
-1,704
| -3% | -$251K | 0.81% | 53 |
|
|
2016
Q3 | $8.56M | Sell |
53,823
-5,176
| -9% | -$798K | 0.98% | 46 |
|
|
2016
Q2 | $8.72M | Sell |
58,999
-4,955
| -8% | -$731K | 1% | 45 |
|
|
2016
Q1 | $9.05M | Sell |
63,954
-11,271
| -15% | -$1.51M | 1.06% | 41 |
|
|
2015
Q4 | $10.7M | Sell |
75,225
-11,205
| -13% | -$1.49M | 1.26% | 24 |
|
|
2015
Q3 | $10.6M | Sell |
86,430
-15,249
| -15% | -$1.99M | 1.21% | 25 |
|
|
2015
Q2 | $13.2M | Sell |
101,679
-20,163
| -17% | -$2.63M | 1.43% | 18 |
|
|
2015
Q1 | $16.4M | Sell |
121,842
-11,183
| -8% | -$1.44M | 1.89% | 9 |
|
|
2014
Q4 | $16.7M | Sell |
133,025
-454
| -0.3% | -$55.2K | 1.87% | 12 |
|
|
2014
Q3 | $16.2M | Sell |
133,479
-1,168
| -0.9% | -$142K | 1.97% | 10 |
|
|
2014
Q2 | $15.9M | Sell |
134,647
-5,789
| -4% | -$681K | 1.93% | 11 |
|
|
2014
Q1 | $16.9M | Sell |
140,436
-22,115
| -14% | -$2.63M | 1.98% | 10 |
|
|
2013
Q4 | $18.1M | Sell |
162,551
-2,250
| -1% | -$224K | 2.12% | 10 |
|
|
2013
Q3 | $15.2M | Sell |
164,801
-1,833
| -1% | -$166K | 1.96% | 11 |
|
|
2013
Q2 | $14.1M | Buy |
+166,634
| New | +$13.9M | 1.94% | 15 |
|
Other funds holding TMO
GW Henssler & Associates's TMO Position: Q2 2026 in Review
GW Henssler & Associates increased its Thermo Fisher Scientific (TMO) stake by 0.74% in Q2 2026, buying an estimated $136K and bringing the position to 38,523 shares worth $19.3M. The position accounts for 0.86% of the portfolio, ranked #46.
GW Henssler & Associates first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $22M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- GW Henssler & Associates held 38,523 shares of Thermo Fisher Scientific worth $19.3M as of Q2 2026.
- GW Henssler & Associates bought 284 Thermo Fisher Scientific shares in Q2 2026, an estimated $136K.
- Thermo Fisher Scientific made up 0.86% of GW Henssler & Associates's portfolio in Q2 2026, its #46 holding.
- GW Henssler & Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- GW Henssler & Associates's Thermo Fisher Scientific position peaked at $22M in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on GW Henssler & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.